TP53 and ovarian carcinoma: In ovarian cancers, the overexpression of CCDC106 promotes cell proliferation and invasion by suppressing p21 transcription through a p53-independent pathway, while CCDC106 knockdown inhibits the expression of proliferation, invasion and EMT signaling markers in mutant p53 cells but not in wild-type p53 cells2.